首頁 > 市場調查報告書 > 醫療設備

電子醫療設備

神經刺激設備市場規模、佔有率和成長分析（按產品、應用和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902337

神經刺激設備市場規模、佔有率和成長分析（按產品、應用和地區分類）－2026-2033年產業預測

Neurostimulation Devices Market Size, Share, and Growth Analysis, By Product (Spinal Cord Stimulator, Deep Brain Stimulator), By Application (Pain Management, Epilepsy), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，神經刺激設備市場規模將達到 67.5 億美元，到 2025 年將成長至 76.1 億美元，到 2033 年將成長至 199.6 億美元，在預測期（2026-2033 年）內複合年成長率為 12.8%。

神經刺激設備市場預計將因神經系統疾病盛行率的上升和神經系統研究投入的增加而顯著成長。人們對這些疾病的認知不斷提高，以及對有效治療方法的需求不斷成長，為該領域的從業者帶來了巨大的機會。基於廣泛研究的技術進步有望促進銷售成長，而微創手術方式的普及也可能進一步刺激需求。此外，神經刺激手術報銷政策的改善以及人們對其益處的認知不斷提高，也將為市場參與者創造新的商機。然而，潛在的併發症、先進設備的高成本以及熟練專業人員的短缺等挑戰可能會阻礙市場的成長前景。

神經刺激設備市場促進因素

神經退化性疾病的增加歸因於不健康的生活方式，導致患有各種神經系統疾病的患者數量顯著增加。帕金森氏症、癲癇、慢性疼痛和憂鬱症疾病的盛行率日益上升，推動了對神經刺激設備的需求。這些設備提供的治療方案能夠改善患者的生活品質，對於管理和治療這些健康問題至關重要。隨著越來越多的人尋求針對這些疾病的有效干預措施，神經刺激技術的重要性與日俱增，凸顯了其在旨在應對複雜神經系統挑戰的現代醫療策略中的核心地位。

限制神經刺激設備市場的因素

由於操作這些先進技術所需的熟練醫療專業人員嚴重短缺，神經刺激設備市場面臨嚴峻挑戰。隨著這些先進醫療設備複雜性的增加，對高素質人員的需求也日益成長。然而，這種專業人才的匱乏可能會阻礙神經刺激設備市場的成長和擴張，因為合格操作人員的缺乏限制了設備的普及和使用。這反過來又會抑制產業的進步和創新潛力，阻礙患者獲得最佳治療效果，並最終使依賴這些重要治療方案的患者受益。

神經刺激設備市場趨勢

在精準醫療需求日益成長的推動下，神經刺激設備市場正經歷著向個人化解決方案的重大轉變。這一趨勢反映出人們越來越認知到患者神經系統特徵的獨特性，從而催生出能夠改善慢性疼痛和癲癇等疾病治療效果的客製化療法。科技的進步使得神經刺激設備能無縫適應特定患者的需求，進而提升患者的治療效果。隨著醫療服務提供者和患者都接受這種個人化方法，預計市場將蓬勃發展，提供不僅能夠緩解症狀，還能有效解決潛在神經系統問題的創新解決方案。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Medtronic（Ireland）
Abbott Laboratories（USA）
Boston Scientific Corporation（USA）
Nevro Corporation（USA）
LivaNova PLC（UK）
NeuroPace, Inc.（USA）
Neuronetics, Inc.（USA）
Axonics Modulation Technologies, Inc.（USA）
Cochlear Limited（Australia）
ElectroCore, Inc.（USA）
Aleva Neurotherapeutics SA（Switzerland）
Soterix Medical（USA）
Bioinduction（United Kingdom）
Oticon Medical（Denmark）

結論與建議

簡介目錄

Product Code: SQMIG35B2087

Neurostimulation Devices Market size was valued at USD 6.75 Billion in 2024 and is poised to grow from USD 7.61 Billion in 2025 to USD 19.96 Billion by 2033, growing at a CAGR of 12.8% during the forecast period (2026-2033).

The neurostimulation devices market is poised for significant growth, driven by increasing prevalence of neurological disorders and escalating investments in neurological research. Rising awareness of these conditions and the corresponding demand for effective treatments present lucrative opportunities for providers in this sector. Technological advancements rooted in extensive research are set to enhance sales, while the shift toward minimally invasive surgical options is likely to further boost demand. Additionally, improved reimbursement options for neurostimulation procedures and heightened awareness of their benefits will create new business avenues for market players. However, challenges such as potential complications, high costs of advanced devices, and a shortage of skilled professionals may hinder market growth prospects.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurostimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurostimulation Devices Market Segments Analysis

Global Neurostimulation Devices Market is segmented by Product, Application and region. Based on Product, the market is segmented intoSpinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator and Gastric Electric Stimulator. Based on Application, the market is segmented into Pain Management, Epilepsy, Essential Tremor, Urinary & Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurostimulation Devices Market

The rise in neurodegenerative diseases can be attributed to unhealthy lifestyle choices, leading to a notable increase in individuals affected by various neurological disorders. Conditions such as Parkinson's disease, epilepsy, chronic pain, and depression have become increasingly prevalent, driving the demand for neurostimulation devices. These devices are essential in managing and treating these health issues, offering therapeutic solutions that enhance patients' quality of life. As more people seek effective interventions for these disorders, the relevance of neurostimulation technology continues to grow, highlighting its importance in contemporary healthcare strategies aimed at addressing complex neurological challenges.

Restraints in the Neurostimulation Devices Market

The neurostimulation devices market faces significant challenges due to a critical shortage of skilled medical professionals required for the effective operation of these sophisticated technologies. As the complexity of these advanced medical devices increases, the demand for highly trained personnel also rises. Unfortunately, this lack of expertise may hinder the growth and expansion of the neurostimulation devices market, as the absence of qualified operators can limit accessibility and utilization. Consequently, the industry's potential for advancement and innovation may be stifled, creating barriers to achieving optimal outcomes and benefiting patients who might rely on these critical therapeutic solutions.

Market Trends of the Neurostimulation Devices Market

The neurostimulation devices market is witnessing a significant shift towards personalized solutions, driven by the growing preference for individualized medicine. This trend reflects an increasing recognition of the unique neurological profiles of patients, leading to tailored therapies that enhance treatment efficacy for conditions such as chronic pain and epilepsy. The advancement in technology allows neurostimulation devices to adapt seamlessly to specific patient needs, fostering improved patient outcomes. As healthcare providers and patients alike embrace these personalized approaches, the market is expected to flourish, providing innovative solutions that not only address symptoms but also target the underlying neurological patterns effectively.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis

Global Neurostimulation Devices Market Size by Product & CAGR (2026-2033)

Market Overview
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulator

Global Neurostimulation Devices Market Size by Application & CAGR (2026-2033)

Market Overview
Pain Management
Epilepsy
Essential Tremor
Urinary & Fecal Incontinence
Depression
Dystonia
Gastroparesis
Parkinson's Disease
Others

Global Neurostimulation Devices Market Size & CAGR (2026-2033)

North America (Product, Application)
- US
- Canada
Europe (Product, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroPace, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuronetics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Axonics Modulation Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cochlear Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ElectroCore, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleva Neurotherapeutics SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soterix Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioinduction (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oticon Medical (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments